Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1977-05-26
1978-11-07
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125LH, A61K 3700, C07C10352
Patent
active
041247035
ABSTRACT:
The disclosure relates to novel polypeptides which are analogues of luliberin and which possess luliberin antagonist activity, to processes for their manufacture and to compositions containing them. Typical of the polypeptides disclosed is ##STR1## in which A is D-Phe, D-Trp or a direct bond.
REFERENCES:
patent: 3928307 (1975-12-01), Foell et al.
A. S. Dutta, et al., Clinical Endocrinology (1976) pp. 291S-298S.
Dutta Anand S.
Giles Michael B.
Imperial Chemical Industries Limited
Phillips Delbert R.
LandOfFree
Luliberin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Luliberin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Luliberin analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2234005